Stress Hyperglycemia Ratio Is Associated with Intracardiac Thrombus in Acute Ischemic Stroke

Vedat Cicek1, Almina Erdem2, Ezgi Hasret Kozan Çıkırıkçı3

  • 1Department of Radiology, Machine and Hybrid Intelligence Lab, Northwestern University, Chicago, IL, United States; Tatvan State Hospital, Bitlis, Türkiye.

Insights

The stress hyperglycemia ratio (SHR) is linked to hidden intracardiac thrombi in acute ischemic stroke (AIS) patients. This finding may improve risk assessment and guide the use of transesophageal echocardiography (TEE).

Area of Science:

  • Cardiology
  • Neurology
  • Biomarker Research

Background:

  • Transthoracic echocardiography (TTE) is standard for cardiac evaluation in acute ischemic stroke (AIS) but can miss intracardiac thrombi.
  • Transesophageal echocardiography (TEE) detects thrombi missed by TTE.
  • Stress hyperglycemia ratio (SHR) is a novel cardiovascular biomarker, but its role in detecting TTE-undetected intracardiac thrombi in AIS is unknown.

Purpose of the Study:

  • To investigate the association between SHR and intracardiac thrombus in AIS patients.
  • To determine if SHR can identify thrombi missed by TTE but detected by TEE.
  • To evaluate SHR's potential in risk stratification for AIS patients.

Main Methods:

  • Retrospective study of 486 AIS patients with negative TTE but positive TEE findings.
  • Analysis of demographic, laboratory, and echocardiographic data.
  • Logistic regression and ROC analysis to assess independent associations with intracardiac thrombus.

Main Results:

  • TEE detected intracardiac thrombus in 13.2% of patients.
  • Patients with thrombus had significantly higher SHR, CRP, and creatinine, and lower ejection fraction.
  • SHR was independently associated with intracardiac thrombus (OR=2.39, P=0.027) after multivariable adjustment.

Conclusions:

  • SHR is significantly associated with intracardiac thrombus missed by TTE in AIS patients.
  • SHR may serve as a valuable biomarker for identifying patients who could benefit from TEE.
  • Elevated SHR could aid in refining risk stratification and guiding the selective use of TEE in AIS.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
2
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
7
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
5
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
2
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
3
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.4K